A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer

Supportive Care in Cancer

Volumn 21, Issue 1, 2013, Pages 211-218

  Videtic, Gregory M M ^a   Reddy, Chandana A ^a   Sorenson, Lisa ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Medically inoperable; Non small cell lung cancer; Pulmonary function; Quality of life; Stage I; Stereotactic body radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER FATIGUE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL EXAMINATION; EARLY CANCER; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; LUNG CANCER; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; STEREOTACTIC BODY RADIATION THERAPY; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; FATIGUE; FEMALE; HEALTH STATUS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOSURGERY; RESPIRATORY FUNCTION TESTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84874032114     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1513-9     Document Type: Article

References (31)

1. Hansen HH (2009) Introduction. In: Hansen HH (ed) Lung Cancer Therapy Annual 6. Informa Health Care, New York, pp 1-6
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249
3. Hansen HH (2009) Histopathology. In: Hansen HH (ed) Lung cancer therapy annual 6. Informa Health Care, New York, pp 45-56
4. Juettner-Smolle FM, Lindenmann J, Matzi V, Neubock N (2010) Resection in stage I/II non-small cell lung cancer. In: Heide J et al (eds) Controversies in the treatment of lung cancer. Karger, Basel, pp 71-77
5. Little AG, Rusch VW, Bonner JA, Gaspar LE, Green MR, Webb WR, Stewart AK (2005) Patterns of surgical care of lung cancer patients. Ann Thorac Surg 80:2051-2056
6. Ginsberg RJ, Rubinstein LV (1995) Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60:615-622
7. Nyman J, Johansson KA, Hultén U (2006) Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients. Lung Cancer 51:97-103
8. Lax I, Blomgren H, Näslund I, Svanström R (1994) Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 33:677-683
9. Stephans KL, Djemil T, Reddy CA et al (2009) A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience. J Thorac Oncol 4:976-982
10. Haasbeek CJ, Lagerwaard FJ, de Jaeger K, Slotman BJ, Senan S (2009) Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy. Cancer 115:587-594
11. Haasbeek CJ, Lagerwaard FJ, Antonisse ME, Slotman BJ, Senan S (2010) Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy. Cancer 116:406-414
12. Hoopes DJ, Tann M, Fletcher JW, Forquer JA, Lin PF, Lo SS, Timmerman RD, McGarry RC (2007) FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Lung Cancer 56:229-234
13. Onishi H, Shirato H, Nagata Y et al (2007) Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2:S94-S100
14. Chang JY, Roth JA (2007) Stereotactic body radiation therapy for stage I non-small cell lung cancer. Thorac Surg Clin 17:251-259
15. Timmerman R, Papiez L, McGarry R et al (2003) Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124:1946-1955
16. Timmerman R, McGarry R, Yiannoutsos C et al (2006) Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24:4833-4839
17. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303:1070-1076
18. Langendijk JA, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Slotman BJ, Wouters EF (2002) Quality of life after curative radiotherapy in Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 53:847-853
19. van der Voort van Zyp NC, Prévost JB, van der Holt B, Braat C, van Klaveren RJ, Pattynama PM, Levendag PC, Nuyttens JJ (2010) Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 77:31-37
20. Lung (2002) In: Greene FL et al. (eds) AJCC cancer staging handbook, 6th edn. Springer, New York, pp 191-204
21. Videtic GM, Stephans K, Reddy C, Gajdos S, Kolar M, Clouser E, Djemil T (2010) Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control. Int J Radiat Oncol Biol Phys 77:344-349
22. Stephans KL, Djemil T, Reddy CA et al (2009) Comprehensive analysis of pulmonary function test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients. J Thorac Oncol 4:838-844
23. Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, Senan S (2008) Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 70:685-692
24. Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P (1995) Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 12:199-220
25. Henoch I, Bergman B, Gustafsson M, Gaston-Johansson F, Danielson E (2007) The impact of symptoms, coping capacity, and social support on quality of life experience over time in patients with lung cancer. J Pain Symptom Manag 34:370-379
26. Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM (1998) Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest 113:619-624
27. http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ ctcaev3.pdf, accessed January 2, 2011
28. Mohan A, Mohan C, Pathak AK, Pandey RM, Guleria R (2007) Impact of chronic obstructive pulmonary disease on respiratory status and quality of life in newly diagnosed patients with lung cancer. Respirology 12:240-247
29. Lima LN, da Silva RA, Gross JL, Deheinzelin D, Negri EM (2009) Assessment of pulmonary function and quality of life in patients submitted to pulmonary resection for cancer. J Bras Pneumol 35:521-528
30. Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16:139-144
31. Sorenson LM, Reddy C, Videtic G (2010) Lessons learned from a prospective study of quality of life in lung cancer patients undergoing stereotactic body radiotherapy: the earlier, the better! Int J Radiat Oncol Biol Phys 78(suppl):S608-S609